Evidence map›Paper›PMID 35108027›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.

Ruth C Carlos, Samilia Obeng-Gyasi, Steven W Cole, Bradley J Zebrack, Etta D Pisano, Melissa A Troester, Lava Timsina, Lynne I Wagner, Jon A Steingrimsson, Ilana Gareen and 3 more

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Guideline
  2. Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Trial
  3. Article
  4. Lung Cancer Screening and Prevention: Beyond Conventional Strategies in a Rapidly Changing Global Milieu.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  11. Article
  12. Article
  13. Neighborhood Disinvestment Predicts Shorter Cancer Survival Time among Black Women Diagnosed with Invasive Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ruth C CarlosUniversity of Michigan, Ann Arbor, MI.ORCID 0000-0001-7055-7662
Samilia Obeng-GyasiThe Ohio State University, Columbus, OH.ORCID 0000-0002-5330-7247
Steven W ColeUniversity of California Los Angeles, Los Angeles, CA.
Bradley J ZebrackUniversity of Michigan, Ann Arbor, MI.
Etta D PisanoBeth Israel Deaconess Medical Center, Boston, MA.
Melissa A TroesterUniversity of North Carolina, Chapel Hill, NC.ORCID 0000-0001-9506-6624
Lava TimsinaIndiana University, Bloomington, IN.ORCID 0000-0001-7493-5843
Lynne I WagnerWake Forest School of Medicine, Winston-Salem, NC.ORCID 0000-0001-9685-4796
Jon A SteingrimssonBrown University, Providence, RI.ORCID 0000-0003-2116-9377
Ilana GareenBrown University, Providence, RI.ORCID 0000-0002-0457-5595
Christoph I LeeUniversity of Washington, Seattle, WA.ORCID 0000-0002-8185-7721
Alyce S AdamsStanford University, Stanford, CA.ORCID 0000-0002-0146-4996
Consuelo H WilkinsVanderbilt University, Nashville, TN.

Funding

ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Preparing For What Is Next With Aducanumab In Real World SettingsR33AG057806 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Christopher Barrett Bowling, Ana Roman Quinones · 2018 to 2026
$9.0M
Leveraging machine learning to improve risk prediction for chemotherapy inducedneuropathyR01CA249127 · NCI · STANFORD UNIVERSITY · PI ADAMS, ALYCE SOPHIA, CHUBAK, JESSICA · 2020 to 2024
$2.7M
NCI NIH HHS P30 CA124435NCI NIH HHS P50 CA058223NCI NIH HHS R01 CA249127NCI NIH HHS UG1 CA189828NIA NIH HHS R33 AG057806NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsRacismBlack or African AmericanFemaleGenomicsHumansSystemic Racism

Identifiers

PMID35108027
PMCPMC9851699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.